Journal of Gastroenterology

, Volume 44, Supplement 19, pp 119–121 | Cite as

Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines

  • Norihiro Kokudo
  • Masatoshi Makuuchi
International Forum 2

Abstract

The “Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC),” the first evidence-based guidelines for the treatment of HCC in Japan, were compiled by an expert panel supported by the Japanese Ministry of Health, Labour, and Welfare. The English translation has been completed (http://www.jsh.or.jp), and its summary has just been published (Hepatol Res 38:37–51, 2008). This set of guidelines covers six research fields: prevention, diagnosis and surveillance, surgery, chemotherapy, transarterial chemoembolization, and percutaneous local ablation therapy. For the users’ convenience, practical algorithms for the surveillance and treatment of HCC were also created, which are based on evidence from articles selected for the guidelines and modified according to the current status of medical practice in Japan. One year after their publication, the J-HCC Guidelines have become well disseminated among both specialists and primary care physicians in Japan. As expected, these guidelines have begun to be applied at every level of clinical decision making for HCC. The first revision of the J-HCC Guidelines is now in process, and it is scheduled to be completed by March 2009.

Key words

hepatocellular carcinoma practice guidelines evidence based medicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ryder SD. Guidelines for the diagnosis and treatment of hepato-cellular carcinoma (HCC) in adults. Gut 2003;52(suppl III):iii1–iii8.PubMedGoogle Scholar
  2. 2.
    Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19(3):329–338.PubMedCrossRefGoogle Scholar
  3. 3.
    Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 2001;35:421–430.PubMedCrossRefGoogle Scholar
  4. 4.
    Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 2002;235(4):466–486.PubMedCrossRefGoogle Scholar
  5. 5.
    Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol 2006;12(5):828–829.PubMedGoogle Scholar
  6. 6.
    Group formed to establish “Guidelines for evidence-based clinical practice for the treatment of liver cancer.” Clinical practice guidelines for hepatocellular carcinoma (in Japanese). Tokyo: Kanehara; 2005.Google Scholar
  7. 7.
    Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara; 2003.Google Scholar
  8. 8.
    Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.PubMedCrossRefGoogle Scholar
  9. 9.
    Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Multiple tumors and concomitant portal hypertension are not operative contraindications for hepatocellular carcinoma. Gastroenterology 2008;134:1908–1916.PubMedCrossRefGoogle Scholar
  10. 10.
    Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, et al. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 2008;38:37–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Kokudo N, Sasaki Y, Nakayama T, Makuuchi M. Dissemination of evidence-based clinical practice guidelines for hepatocellular carcinoma among Japanese hepatologists, liver surgeons, and primary care physicians. Gut 2007;56(7):1020–1021.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2009

Authors and Affiliations

  • Norihiro Kokudo
    • 1
  • Masatoshi Makuuchi
    • 2
  1. 1.Department of Surgery, Hepato-Biliary-Pancreatic Surgery Division, Artificial Organ and Transplantation DivisionUniversity of TokyoTokyoJapan
  2. 2.Japan Red Cross Medical CenterTokyoJapan

Personalised recommendations